ClinicalTrials.gg
CompletedNCT03387735Updated Sep 1, 2022Results posted

Multiple Chronic Conditions for Older Adults

An interventional study of Treatment as usual (TAU) + Internet and TAU + ElderTree in Chronic Disease, sponsored by University of Wisconsin, Madison. Completed at 1 site in United States. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-09-01.

Primary conditionChronic Disease(the registry's first term)UnverifiedIs this wrong?Chronic Disease is a broad heading, used only when no more specific condition is named. No better condition is named, so the registry's term is kept.

Sponsored by University of Wisconsin, Madison · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
346
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

Multiple chronic conditions are common and expensive among patients aged ≥65 and are associated with lower quality of life, poorer response to treatment, worse medical and psychiatric outcomes, higher mortality, and higher costs of care.

The primary purpose of this study is to conduct a randomized clinical trial (RCT) to examine the effects of ElderTree --a web-based intervention--on health outcomes and healthcare use among older adults with several chronic health conditions, such as diabetes, high blood pressure, high cholesterol, COPD, BMI over 30, congestive heart failure, chronic kidney disease, arrhythmia/atrial fibrillation, chronic pain, arthritis.

The investigator's hypothesis is that patients assigned to TAU+ElderTree will have better quality of life and fewer primary care visits than those assigned to TAU+Internet.

02

Conditions studied

  • Chronic Disease

Keywords

  • Hypertension, Hyperlipidemia, Diabetes, Arthritis, Obesity
03

In context

Chronic Disease Unverified

781 studies on the registry are indexed under Chronic Disease; 144 are open to participants now.

This study's enrollment of 346 is above the median of 140 across 582 interventional studies indexed under Chronic Disease.

Browse Chronic Disease studies →

Lead sponsor

University of Wisconsin, Madison is the lead sponsor of 1,189 studies on the registry; 182 are open to participants now.

Of its 157 completed or terminated interventional studies of FDA-regulated products, 118 (75%) have results posted.

Compared within Chronic Disease, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:

  1. are ≥65 years old
  2. have been treated in the University of Wisconsin Health clinics for at least the previous 18 months with no plans to leave during the study period
  3. have 3 or more of the following chronic conditions: hypertension, hyperlipidemia, diabetes, arthritis, over 30, chronic kidney disease, congestive heart failure, arrhythmia/atrial fibrillation, pulmonary heart disease or pulmonary vascular disease, chronic pain,
  4. report no current psychotic disorder that would prevent participation
  5. have no acute medical problem requiring immediate hospitalization
  6. be able to read and sign the consent form in English
  7. have no known terminal illness
  8. be willing to share health-related study data and

    • Systolic and diastolic BP
    • Weight
    • BMI
    • HDL/LDL
    • pain score
    • lung function
    • health care utilization: number of ER visits, urgent care visits, primary care visits and specialty care visits
  9. allow researchers to share information with their primary care physician
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

HbA1c

A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
346 participants (actual)

Study arms

  • Placebo comparator
    Treatment as usual (TAU) + Internet

    Patients will be given access to helpful websites such as National Institute on Aging.

    Other: Treatment as usual (TAU) + Internet

  • Experimental
    Treatment as usual (TAU) + ElderTree

    Patients will be given access to the ElderTree website for 12 months which provides tools, motivation, and social support to help them manage their specific set of chronic conditions and communicate with peers and their primary care physician.

    Behavioral: TAU + ElderTree

Interventions

  • OtherTreatment as usual (TAU) + Internet

    Patients in this group will receive TAU+internet and links to helpful websites.

  • BehavioralTAU + ElderTree

    For the patient, ElderTree provides tools, motivation, and social support to help them manage their specific set of chronic conditions and communicate with peers and their primary care physician. For the clinic, ElderTree has a Clinician Report (CR), a visual dashboard of health-tracking data that can be customized based on the needs of the clinic. The CR provides alerts to the clinician when a patient passes a certain threshold. The dashboard is intended to help clinicians prepare for patient office visits.

06

What researchers measure

Primary outcomes

  1. PROMIS Global Health Measure Score

    Quality of life is assessed using the Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health measure. For consistency with other measures, the time frame has been modified to refer to the past 2 weeks. Scores are calculated using the HealthMeasures Scoring Service. Scores are a T-score metric with a mean of 50 and a standard deviation of 10 with a range of about 20 to 80. Higher scores indicate better quality of life.

    Time frame: Measured at baseline and 12 months

  2. Psychological Flourishing Scale

    Psychological well-being is assessed using the Psychological Flourishing Scale. The wording of items has been somewhat modified, including simplifying double-barreled items. For example, "I lead a purposeful and meaningful life" is shortened to "I lead a meaningful life." Scores are a sum of all items with a range from 8 to 40. Higher scores indicate a better well-being.

    Time frame: Baseline and 12-months

  3. UCLA Loneliness Scale

    Loneliness is measured using the 8 items from the UCLA Loneliness Scale with the highest factor loadings among older adults. Scores ranged from 8 to 40. Higher scores indicate more loneliness.

    Time frame: Baseline and 12-months

Secondary outcomes

  1. Unhealthy Laboratory Scores

    Laboratory scores are obtained from the patient's electronic health record (EHR) including blood pressure, HAC1 for diabetes, cholesterol, BMI. Some participants did not have this data. The final score is a fraction of the number of unhealthy labs over each persons total labs. Scores range from 0 to 1. Higher scores indicate more unhealthy lab records.

    Time frame: 12-months

  2. Falls

    Falls were assessed by asking how often the participant had fallen in the past 3 months. A fall is defined in the survey as "the body going to the ground without being pushed." Here we report statistics for how many times participants had fallen. Falls ranged from 0 to 14.

    Time frame: Baseline and 12-months

  3. Symptom Distress

    Symptom distress is assessed using a combined list of 20 symptoms and chronic conditions from the General Symptom Distress Scale and Bayliss Disease Burden Scale, assessing the severity of distress for each over the past 2 weeks (0=do not have this, 1=not very distressing, and 5=extremely distressing). Scores range from 0 to 100. Higher scores indicate more symptom distress.

    Time frame: Baseline and 12-months

  4. Medication Adherence

    Medication adherence is assessed with 8 items, 6 based on the Brief Medication Questionnaire by Svarstad et al. We simplified response options so that participants rate how often they had specific issues with medication (1=never and 5=always). On the basis of patients' experiences, we added 2 original items, "Feels like I no longer need it" and "Feels like I don't need the full dose. There were 8 items in total, summed to get a final score. Scores ranged from 8 to 40. Higher scores indicate less medication adherence.

    Time frame: Baseline and 12-months

  5. Crisis Health Care Visits

    Crisis health care was the total number of urgent care visits, emergency room visits, and hospitalizations combined. Reported is the average count of visits. Higher numbers indicate more visits.

    Time frame: Baseline and 12-months

  6. Long-term Care

    Long-term care was the number of nights spent in assisted living facilities and nursing homes over the past 3 months. Number of nights ranged from 0 to 92. Higher numbers indicate more nights spent.

    Time frame: Baseline and 12-months

  7. Falls Requiring Medical Attention

    Falls requiring medical attention was assessed by one item counting the number of times in the past 3 months. A fall is defined in the survey as "the body going to the ground without being pushed." Here we report statistics for how many times participants had fallen and required medical attention. Falls needing medical attention ranged from 0 to 4.

    Time frame: Baseline and 12-months

07

Results

Posted Sep 1, 2022
Limitations and caveats
We did not have health lab score baseline data for all participants

Participant flow

Recruitment was conducted from January 2018 to December 2019. The intervention period ended in June 2021.

Participant flow — Overall Study
MilestoneTreatment as Usual (TAU) + InternetTreatment as Usual (TAU) + ElderTree
Started168176
Completed160160
Not completed816
Withdrew: Lost to follow-up48
Withdrew: Death48

Outcome measures

PrimaryPROMIS Global Health Measure Score

Quality of life is assessed using the Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health measure. For consistency with other measures, the time frame has been modified to refer to the past 2 weeks. Scores are calculated using the HealthMeasures Scoring Service. Scores are a T-score metric with a mean of 50 and a standard deviation of 10 with a range of about 20 to 80. Higher scores indicate better quality of life.

Time frame:
Measured at baseline and 12 months
Reported as:
Mean · T-score
PROMIS Global Health Measure Score
T-scoreTreatment as Usual (TAU) + InternetTreatment as Usual (TAU) + ElderTree
Baseline: Mental46.27 ± 7.4246.21 ± 7.16
12 Months: Mental44.92 ± 6.8246.38 ± 7.34
Baseline: Physical42.40 ± 6.5042.35 ± 5.99
12 Months: Physical42.13 ± 6.3042.41 ± 6.32
PrimaryPsychological Flourishing Scale

Psychological well-being is assessed using the Psychological Flourishing Scale. The wording of items has been somewhat modified, including simplifying double-barreled items. For example, "I lead a purposeful and meaningful life" is shortened to "I lead a meaningful life." Scores are a sum of all items with a range from 8 to 40. Higher scores indicate a better well-being.

Time frame:
Baseline and 12-months
Reported as:
Mean · score on a scale
Psychological Flourishing Scale
score on a scaleTreatment as Usual (TAU) + InternetTreatment as Usual (TAU) + ElderTree
Baseline31.55 ± 5.3931.12 ± 5.08
12-months31.50 ± 5.1531.48 ± 5.60
PrimaryUCLA Loneliness Scale

Loneliness is measured using the 8 items from the UCLA Loneliness Scale with the highest factor loadings among older adults. Scores ranged from 8 to 40. Higher scores indicate more loneliness.

Time frame:
Baseline and 12-months
Reported as:
Mean · score on a scale
UCLA Loneliness Scale
score on a scaleTreatment as Usual (TAU) + InternetTreatment as Usual (TAU) + ElderTree
Baseline16.02 ± 5.7717.12 ± 6.04
12-months16.05 ± 6.2716.75 ± 5.86
SecondaryUnhealthy Laboratory Scores

Laboratory scores are obtained from the patient's electronic health record (EHR) including blood pressure, HAC1 for diabetes, cholesterol, BMI. Some participants did not have this data. The final score is a fraction of the number of unhealthy labs over each persons total labs. Scores range from 0 to 1. Higher scores indicate more unhealthy lab records.

Time frame:
12-months
Reported as:
Mean · fraction of unhealthy lab scores
Unhealthy Laboratory Scores
fraction of unhealthy lab scoresTreatment as Usual (TAU) + InternetTreatment as Usual (TAU) + ElderTree
Unhealthy Laboratory Scores0.64 ± 0.310.64 ± 0.34
SecondaryFalls

Falls were assessed by asking how often the participant had fallen in the past 3 months. A fall is defined in the survey as "the body going to the ground without being pushed." Here we report statistics for how many times participants had fallen. Falls ranged from 0 to 14.

Time frame:
Baseline and 12-months
Reported as:
Mean · falls
Falls
fallsTreatment as Usual (TAU) + InternetTreatment as Usual (TAU) + ElderTree
Baseline0.36 ± 0.950.36 ± 0.88
12-months0.36 ± 0.890.72 ± 4.09
SecondarySymptom Distress

Symptom distress is assessed using a combined list of 20 symptoms and chronic conditions from the General Symptom Distress Scale and Bayliss Disease Burden Scale, assessing the severity of distress for each over the past 2 weeks (0=do not have this, 1=not very distressing, and 5=extremely distressing). Scores range from 0 to 100. Higher scores indicate more symptom distress.

Time frame:
Baseline and 12-months
Reported as:
Mean · score on a scale
Symptom Distress
score on a scaleTreatment as Usual (TAU) + InternetTreatment as Usual (TAU) + ElderTree
Baseline21.10 ± 14.5620.58 ± 14.55
12-months18.86 ± 14.8918.58 ± 14.14
SecondaryMedication Adherence

Medication adherence is assessed with 8 items, 6 based on the Brief Medication Questionnaire by Svarstad et al. We simplified response options so that participants rate how often they had specific issues with medication (1=never and 5=always). On the basis of patients' experiences, we added 2 original items, "Feels like I no longer need it" and "Feels like I don't need the full dose. There were 8 items in total, summed to get a final score. Scores ranged from 8 to 40. Higher scores indicate less medication adherence.

Time frame:
Baseline and 12-months
Reported as:
Mean · score on a scale
Medication Adherence
score on a scaleTreatment as Usual (TAU) + InternetTreatment as Usual (TAU) + ElderTree
Baseline13.14 ± 4.3613.07 ± 3.88
12-months12.70 ± 4.2312.56 ± 4.07
SecondaryCrisis Health Care Visits

Crisis health care was the total number of urgent care visits, emergency room visits, and hospitalizations combined. Reported is the average count of visits. Higher numbers indicate more visits.

Time frame:
Baseline and 12-months
Reported as:
Mean · visits
Crisis Health Care Visits
visitsTreatment as Usual (TAU) + InternetTreatment as Usual (TAU) + ElderTree
Baseline0.42 ± 0.900.45 ± 1.06
12-months0.86 ± 1.760.76 ± 1.45
SecondaryLong-term Care

Long-term care was the number of nights spent in assisted living facilities and nursing homes over the past 3 months. Number of nights ranged from 0 to 92. Higher numbers indicate more nights spent.

Time frame:
Baseline and 12-months
Reported as:
Mean · nights
Long-term Care
nightsTreatment as Usual (TAU) + InternetTreatment as Usual (TAU) + ElderTree
Baseline0.01 ± 0.150.25 ± 2.50
12-months0.79 ± 7.760.29 ± 2.11
SecondaryFalls Requiring Medical Attention

Falls requiring medical attention was assessed by one item counting the number of times in the past 3 months. A fall is defined in the survey as "the body going to the ground without being pushed." Here we report statistics for how many times participants had fallen and required medical attention. Falls needing medical attention ranged from 0 to 4.

Time frame:
Baseline and 12-months
Reported as:
Mean · falls requiring medical attention
Falls Requiring Medical Attention
falls requiring medical attentionTreatment as Usual (TAU) + InternetTreatment as Usual (TAU) + ElderTree
Baseline0.23 ± 0.500.18 ± 0.39
12-months0.33 ± 0.840.16 ± 0.37

Adverse events

Collected over up to 18 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Treatment as Usual (TAU) + Internet4/168 (2.4%)0/168 (0%)0/168 (0%)
Treatment as Usual (TAU) + ElderTree8/176 (4.5%)0/176 (0%)0/176 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Treatment as Usual (TAU) + InternetTreatment as Usual (TAU) + ElderTreeTotal
Mean74.54 ± 6.4575.03 ± 6.2774.79 ± 6.36
Sex: Female, Male
Sex: Female, Male(Participants)Treatment as Usual (TAU) + InternetTreatment as Usual (TAU) + ElderTreeTotal
Female103106209
Male6570135
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Treatment as Usual (TAU) + InternetTreatment as Usual (TAU) + ElderTreeTotal
Hispanic or Latino101
Not Hispanic or Latino167176343
Unknown or Not Reported000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Treatment as Usual (TAU) + InternetTreatment as Usual (TAU) + ElderTreeTotal
American Indian or Alaska Native000
Asian000
Native Hawaiian or Other Pacific Islander000
Black or African American14822
White153164317
More than one race145
Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(participants)Treatment as Usual (TAU) + InternetTreatment as Usual (TAU) + ElderTreeTotal
United States168176344
Health Insurance type
Health Insurance type(Participants)Treatment as Usual (TAU) + InternetTreatment as Usual (TAU) + ElderTreeTotal
Medicare5769126
Medicaid213
Affordable Care Act000
Military000
Private insurance325
Covered under someone else000
No insurance000
NA112
More than one source105103208
08

Study locations

1 site
  • UW Health Clinics
    Madison, Wisconsin 53704, United States
09

References and documents

Publications

  • Gustafson DH Sr, Mares ML, Johnston DC, Mahoney JE, Brown RT, Landucci G, Pe-Romashko K, Cody OJ, Gustafson DH Jr, Shah DV. A Web-Based eHealth Intervention to Improve the Quality of Life of Older Adults With Multiple Chronic Conditions: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2021 Feb 19;10(2):e25175. doi: 10.2196/25175. PubMed 33605887 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2018 to primary completion in Jun 2021, 41 months.

Results were first posted in Sep 2022, 1 year 2 months after primary completion.

Of 318 non-industry interventional studies with no phase under Chronic Disease, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 33. This study's 41 months is above that.

Counting every sponsor, half of 328 studies reached it within 21 months; a quarter within 11 and three quarters within 33.

Chronic Disease covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 2, 2017
First posted
Jan 2, 2018
StartActual
Jan 1, 2018
Primary completionActual
Jun 29, 2021
CompletionActual
Jun 29, 2021
Results first posted
Sep 1, 2022
Last update
Sep 1, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 1, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03387735
Responsible party
Sponsor
First posted
Jan 2, 2018
Start date
Jan 1, 2018
Primary completion
Jun 29, 2021
Completion
Jun 29, 2021
Results posted
Sep 1, 2022
Last update
Sep 1, 2022

Study contacts

David H Gustafson, PhD
principal investigator · University of Wisconsin, Madison

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion